Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide
- Development stage
- Preclinical
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the chemical formula C25H16F2N4O3 and a molecular weight of approximately 458.42 g/mol. It belongs to the class of aromatic anilides and features both fluorinated phenyl and pyrrolopyridine moieties. The compound has been studied as an experimental agent in drug discovery programs but does not have established clinical use or approved therapeutic indications. Computational studies suggest it may act as an inhibitor of viral proteins such as the nsp16/nsp10 complex involved in SARS-CoV‑2 RNA methylation, indicating potential antiviral activity; however, there are no confirmed mechanisms or clinical data supporting its efficacy or safety in humans[6]. Its primary use to date is for research purposes.
- Other names
- N-(3-fluoro–4-{1H-pyrrolo[2,3-b]pyridin–4-yloxy}phenyl)-1-(4-fluorophenyl)-2–oxo–1,2-dihydropyridine–3-carboxamide
02
Targets
nsp16 (Non-structural protein 16/Non-structural protein 10 complex)
Beyond the preview
Go deeper on 1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide.